107 related articles for article (PubMed ID: 27906773)
1. Suppression of AIMP1 protects cognition in Alzheimer's disease model mice 3xTg-AD.
Jang S; Lee JH; Sohn BK; Kim E; Park SG; Yoon KJ; Park M; Kim EW; Jeong J; Lee JY; Kim CH; Namkoong K
Neuroreport; 2017 Jan; 28(2):82-86. PubMed ID: 27906773
[TBL] [Abstract][Full Text] [Related]
2. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
3. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.
Guzmán-Ramos K; Moreno-Castilla P; Castro-Cruz M; McGaugh JL; Martínez-Coria H; LaFerla FM; Bermúdez-Rattoni F
Learn Mem; 2012 Sep; 19(10):453-60. PubMed ID: 22984283
[TBL] [Abstract][Full Text] [Related]
4. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
García-Mesa Y; López-Ramos JC; Giménez-Llort L; Revilla S; Guerra R; Gruart A; Laferla FM; Cristòfol R; Delgado-García JM; Sanfeliu C
J Alzheimers Dis; 2011; 24(3):421-54. PubMed ID: 21297257
[TBL] [Abstract][Full Text] [Related]
5. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.
Sabogal-Guáqueta AM; Muñoz-Manco JI; Ramírez-Pineda JR; Lamprea-Rodriguez M; Osorio E; Cardona-Gómez GP
Neuropharmacology; 2015 Jun; 93():134-45. PubMed ID: 25666032
[TBL] [Abstract][Full Text] [Related]
6. Early Intervention with a Multi-Ingredient Dietary Supplement Improves Mood and Spatial Memory in a Triple Transgenic Mouse Model of Alzheimer's Disease.
Hutton CP; Lemon JA; Sakic B; Rollo CD; Boreham DR; Fahnestock M; Wojtowicz JM; Becker S
J Alzheimers Dis; 2018; 64(3):835-857. PubMed ID: 29914019
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.
Baazaoui N; Iqbal K
J Alzheimers Dis; 2017; 58(1):215-230. PubMed ID: 28387677
[TBL] [Abstract][Full Text] [Related]
8. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
[TBL] [Abstract][Full Text] [Related]
9. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
10. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.
Cantarella G; Di Benedetto G; Puzzo D; Privitera L; Loreto C; Saccone S; Giunta S; Palmeri A; Bernardini R
Brain; 2015 Jan; 138(Pt 1):203-16. PubMed ID: 25472798
[TBL] [Abstract][Full Text] [Related]
12. Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer's disease.
Kong V; Devenyi GA; Gallino D; Ayranci G; Germann J; Rollins C; Chakravarty MM
Brain Struct Funct; 2018 Sep; 223(7):3365-3382. PubMed ID: 29948190
[TBL] [Abstract][Full Text] [Related]
13. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis.
Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X
J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456
[TBL] [Abstract][Full Text] [Related]
14. Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice.
Hu Y; Lai J; Wan B; Liu X; Zhang Y; Zhang J; Sun D; Ruan G; Liu E; Liu GP; Chen C; Wang DW
Neurotoxicology; 2016 Mar; 53():290-300. PubMed ID: 26945731
[TBL] [Abstract][Full Text] [Related]
15. IVIg protects the 3xTg-AD mouse model of Alzheimer's disease from memory deficit and Aβ pathology.
St-Amour I; Paré I; Tremblay C; Coulombe K; Bazin R; Calon F
J Neuroinflammation; 2014 Mar; 11():54. PubMed ID: 24655894
[TBL] [Abstract][Full Text] [Related]
16. Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD).
Filali M; Lalonde R; Theriault P; Julien C; Calon F; Planel E
Behav Brain Res; 2012 Oct; 234(2):334-42. PubMed ID: 22796601
[TBL] [Abstract][Full Text] [Related]
17. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss.
Ager RR; Davis JL; Agazaryan A; Benavente F; Poon WW; LaFerla FM; Blurton-Jones M
Hippocampus; 2015 Jul; 25(7):813-26. PubMed ID: 25530343
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease.
Llorente-Ovejero A; Manuel I; Lombardero L; Giralt MT; Ledent C; Giménez-Llort L; Rodríguez-Puertas R
J Alzheimers Dis; 2018; 64(1):117-136. PubMed ID: 29865071
[TBL] [Abstract][Full Text] [Related]
19. Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice.
Cao C; Wang L; Lin X; Mamcarz M; Zhang C; Bai G; Nong J; Sussman S; Arendash G
J Alzheimers Dis; 2011; 25(2):323-35. PubMed ID: 21422521
[TBL] [Abstract][Full Text] [Related]
20. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]